Researchers from the University of Sydney published a review this week, concluding that industry-funded drug trials are often biased in favor of the sponsors’ products.
According to Lisa Bero of the university’s Charles Perkins Centre, the study provides “definitive evidence that pharmaceutical industry funding of drug studies biases the results and conclusions to look favourable towards the drug of the sponsor.”
Get the full story at our sister site, Drug Delivery Business News.
The post Study: Industry funding biases drug trials in favor of sponsors appeared first on MassDevice.
from MassDevice http://ift.tt/2l4O8wa
Cap comentari:
Publica un comentari a l'entrada